FDA Approves First CRISPR Treatment in U.S.

Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.

Related Keywords

Massachusetts ,United States ,California ,Berkeley ,Jennifer Doudna ,Nicole Verdun ,Monica Bhatia ,Markus Mapara ,Emmanuelle Charpentier ,Drug Administration ,Vertex Pharmaceuticals ,University Of California ,Nobel Prize ,Biologics Evaluation ,Sharl Azar ,Massachusetts General ,Rich Colvin ,